| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $12.3M | +19.9% |
| SG&A Expense | $7.2M | -15.2% |
| Operating Income | -$19.4M | -4.0% |
| Interest Expense | $56K | +74.8% |
| Income Tax | $0 | — |
| Net Income | -$18.5M | -5.6% |
| EPS (Basic) | -$103.61 | -7574.8% |
| EPS (Diluted) | -$103.61 | -7574.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -44.3% |
| Current Assets | $4.5M | -39.6% |
| Total Assets | $5.2M | -31.9% |
| Current Liabilities | $3.5M | -19.7% |
| Total Liabilities | $3.5M | -18.8% |
| Stockholders' Equity | $1.6M | -49.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -14.7% |
| Capital Expenditures | $36K | -64.7% |
| Investing Cash Flow | -$36K | +64.7% |
| Financing Cash Flow | $15.9M | — |
| Free Cash Flow | -$18.1M | -14.2% |